WHO to begin using 2nd Ebola vaccine in Congo
Sept. 23 (UPI) -- The World Health Organization said Monday it will start using a second Ebola vaccine amid an outbreak in the Democratic Republic of the Congo.
The group said the vaccine, developed by Johnson & Johnson, is given in two doses 56 days apart and complements the initial inoculation. The first vaccine is intended for patients who has been exposed to a confirmed case of Ebola.
"The DRC authorities, in deciding to deploy the second experimental vaccine to extend protection against this deadly virus, have once again shown leadership and their determination to end this outbreak as soon as possible," WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement.
More than 223,000 Congolese have so far received the initial vaccine. The WHO said there are enough vaccines on the ground to meet current needs.
Nearly 1,000 people have been successfully treated and released from Ebola treatment centers in the Congo, the agency said.
"We expect that the 1,000th survivor will return to his or her community in the coming weeks," WHO Regional Director for Africa Dr. Matshidiso Moeti said.
Earlier this month, the WHO said it needs more funding -- $287 million -- to fight the Ebola virus in the DRC through the end of the year.
The World Health Organisation (WHO) said on Monday Congo would introduce a second vaccine against Ebola from mid-October, as the country continues to battle the second-worst outbreak of the disease in history. The WHO Director-General, Tedros
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus. The Democratic Republic of Congo (DRC) has announced plans to utilise a second Ebola vaccine
The Democratic Republic of Congo will introduce a second Ebola vaccine next month, the World Health Organization said Monday, as a top medical charity accused the UN agency of rationing doses. DRC's latest
In this Saturday, July 13, 2019 file photo, a child is vaccinated against Ebola in Beni, Congo. The World Health Organization says Monday, Sept. 23, 2019 Congo will start using a second experimental Ebola vaccine,
The health authorities in the Democratic Republic of the Congo (DRC) have announced plans to introduce a second experimental Ebola vaccine, manufactured by Johnson & Johnson, from mid- October. This vaccine, which is given as
The health authorities in the Democratic Republic of the Congo (DRC) have announced plans to introduce a second experimental Ebola vaccine, manufactured by Johnson & Johnson, from mid- October. This vaccine, which is given
LONDON (Reuters) - A rigid system of eligibility set by the World Health Organization means far too few people at risk of Ebola are being vaccinated in an outbreak in Democratic Republic of Congo, the
More News in Health
The recall was conducted in coordination with the US Food and Drug Administration (FDA), after finished product batches were manufactured with active pharmaceutical ingredient (API) produced by Hetero Labs - a company involved in previous
MANILA, Philippines - The World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) on Thursday expressed concern over the re-emergence of poliovirus in the Philippines 19 years after it was declared
MANILA, Philippines - Department of Health (DOH) Secretary Francisco Duque III on Thursday called on the public to join in the government's synchronized vaccination program on polio following confirmation of its re-emergence in
If you fail to get yourself checked and treated on time, you may go through complications like severe abdominal pain, persistent vomiting, blood in your urine, bleeding from your gums, difficulty in breathing etc.
Genetic engineering has delivered monumental scientific, technological, and humanitarian achievements - from producing human insulin in bacteria and gene therapy to treat genetic diseases to increasing food security and reducing malnutrition in developing countries.